Clinical Trials Logo
  1. Home
  2. Diabetes Mellitus, Type 2
  3. NCT02750111
  4. Details
NCT02750111 Clinical Trial

Continuous Glucose Monitoring During Intecorse in Young Adults With Type 1 Diabetes

Diabetes Mellitus Type 1 Clinical Trial

Official title:
Continuous Glucose Monitoring During Intecorse in Young Adults With Type 1 Diabetes

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02750111
Other study ID # 2942.1
Secondary ID
Status Recruiting
Phase N/A
First received April 18, 2016
Last updated October 18, 2017
Start date May 2016
Est. completion date May 8, 2018

Study information
Verified date October 2017
Source Sheba Medical Center
Contact Orit Hamiel, Prof.
Phone +97235305015
Email orit.hamiel@sheba.health.gov.il
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Determine the incidence of hypoglycemia during / after sexual intercourse among young adults with type 1 diabetes using continuous -type sugar meter IPRO for a week.

Description:

Determine the incidence of hypoglycemia during / after sexual intercourse among young adults with type 1 diabetes using continuous -type sugar meter IPRO for a week.

Recruitment information / eligibility
Status Recruiting
Enrollment 50
Est. completion date May 8, 2018
Est. primary completion date May 8, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

type 1 diabetes

Exclusion Criteria:

type 2 diabetes other concomitant disease

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Israel Sheba_Medical_Center Ramat Gan

Sponsors (2)
Lead Sponsor Collaborator
Dr. Orit Hamiel Sheba Medical Center

Country where clinical trial is conducted

Israel, 

Outcome
Type Measure Description Time frame Safety issue
Primary Blood Glucose Continuous glucose monitor for a week week
See also
  Status Clinical Trial Phase
Recruiting NCT01508065 - Measuring and Monitoring Blood Glucose Levels Utilizing Non-invasive Blood Glucose Monitoring Device
Completed NCT01788033 - Effects of XOMA 052 on Insulin Production in Type 1 Diabetes Phase 2
Active, not recruiting NCT01271517 - Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis Phase 4
Recruiting NCT01800734 - Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study Phase 4
Recruiting NCT06088615 - Feasibility of Non-invasive Glucose Monitoring by Using Photothermal Deflectometry
Completed NCT02127047 - Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes Phase 2
Completed NCT01689090 - Diameter Changes of Retinal Vessels During Hypoxia N/A
Completed NCT00006505 - Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression Phase 2
Not yet recruiting NCT06217302 - Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease Phase 3
Recruiting NCT02545062 - MoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without Diabetes N/A
Completed NCT02146651 - A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes Phase 2
Completed NCT02538120 - Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1 Patients N/A
Completed NCT02403375 - Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 Diabetes N/A
Terminated NCT00896610 - Natural History of Autoimmune Diabetes and Its Complications
Terminated NCT02701257 - The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas N/A
Completed NCT02094534 - A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics Phase 2
Completed NCT01334151 - Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 Diabetes Phase 1
Active, not recruiting NCT02624804 - A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes Phase 1
Completed NCT02465411 - Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections N/A
Completed NCT02157155 - A Study of Intracellular Signaling in Muscle and Fat Cells During Ketosis N/A